BMC Psychiatry (Dec 2018)

Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in a randomized trial

  • Christopher Hautmann,
  • Manfred Döpfner,
  • Josepha Katzmann,
  • Stephanie Schürmann,
  • Tanja Wolff Metternich-Kaizman,
  • Charlotte Jaite,
  • Viola Kappel,
  • Julia Geissler,
  • Andreas Warnke,
  • Christian Jacob,
  • Klaus Hennighausen,
  • Barbara Haack-Dees,
  • Katja Schneider-Momm,
  • Alexandra Philipsen,
  • Swantje Matthies,
  • Michael Rösler,
  • Wolfgang Retz,
  • Alexander von Gontard,
  • Esther Sobanski,
  • Barbara Alm,
  • Sarah Hohmann,
  • Alexander Häge,
  • Luise Poustka,
  • Michael Colla,
  • Laura Gentschow,
  • Christine M. Freitag,
  • Katja Becker,
  • Thomas Jans

DOI
https://doi.org/10.1186/s12888-018-1963-9
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background The efficacy of parent-child training (PCT) regarding child symptoms may be reduced if the mother has attention-deficit/hyperactivity disorder (ADHD). The AIMAC study (ADHD in Mothers and Children) aimed to compensate for the deteriorating effect of parental psychopathology by treating the mother (Step 1) before the beginning of PCT (Step 2). This secondary analysis was particularly concerned with the additional effect of the Step 2 PCT on child symptoms after the Step 1 treatment. Methods The analysis included 143 mothers and children (aged 6–12 years) both diagnosed with ADHD. The study design was a two-stage, two-arm parallel group trial (Step 1 treatment group [TG]: intensive treatment of the mother including psychotherapy and pharmacotherapy; Step 1 control group [CG]: supportive counseling only for mother; Step 2 TG and CG: PCT). Single- and multi-group analyses with piecewise linear latent growth curve models were applied to test for the effects of group and phase. Child symptoms (e.g., ADHD symptoms, disruptive behavior) were rated by three informants (blinded clinician, mother, teacher). Results Children in the TG showed a stronger improvement of their disruptive behavior as rated by mothers than those in the CG during Step 1 (Step 1: TG vs. CG). In the CG, according to reports of the blinded clinician and the mother, the reduction of children’s disruptive behavior was stronger during Step 2 than during Step 1 (CG: Step 1 vs. Step 2). In the TG, improvement of child outcome did not differ across treatment steps (TG: Step 1 vs. Step 2). Conclusions Intensive treatment of the mother including pharmacotherapy and psychotherapy may have small positive effects on the child’s disruptive behavior. PCT may be a valid treatment option for children with ADHD regarding disruptive behavior, even if mothers are not intensively treated beforehand. Trial registration ISRCTN registry ISRCTN73911400. Registered 29 March 2007.

Keywords